A Multicenter Real-World Data of Cladribine Tablets in Patients with Multiple Sclerosis in Turkey

被引：0
|
作者：
Koseoglu, Mesrure [1 ]
Omerhoca, Sami [2 ]
Balci, Fatma Belgin [3 ]
Unal, Aysun [4 ]
Ozdemir, Zeynep [1 ]
Yuksel, Burcu [1 ]
Celik, Rabia Gokcen Gozubatik [1 ]
Toprak, Ufuk Emre [5 ]
Gursoy, Esra Azize [6 ]
Icen, Nilufer Kale [2 ]
Altunrende, Burcu [7 ]
机构：
[1] Univ Hlth Sci, Bakirkoy Res & Training Hosp Neurol & Psychiat Di, Dept Neurol, Istanbul, Turkiye
[2] SBU Bagcilar Training & Res Hosp, Dept Neurol, Istanbul, Turkiye
[3] Haseki Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye
[4] Tekirdag Namik Kemal Univ, Dept Neurol, Fac Med, Tekirdag, Turkiye
[5] Istanbul Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye
[6] Basaksehir Cam & Sakura City Hosp, Dept Neurol, Istanbul, Turkiye
[7] Taksim Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1598/1823
引用
收藏
页码：1017 / 1017
页数：1
相关论文
共 50 条
  • [1] Real-World Outcomes With Cladribine Tablets in People With Relapsing Multiple Sclerosis
    Okuda, Darin
    Livingston, Terrie
    Moog, Tatum
    Smith, Alexander
    Lebson, Lori
    Piette, Elizabeth
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1100 - 1100
  • [2] 5 YEARS OF REAL-WORLD DATA ON THE USE OF CLADRIBINE TABLETS FOR THE TREATMENTS OF MULTIPLE SCLEROSIS IN PORTUGAL
    Ribeiro, M.
    Pinto, D.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S16 - S16
  • [3] Cladribine tablets in people with relapsing multiple sclerosis: a real-world multicentric, multinational study
    Adamec, I.
    Jakob, G. Brec
    Rajda, C.
    Drulovic, J.
    Radulovic, L.
    Kes, V. Basic
    Lazibat, I.
    Rimac, J.
    Cindric, I.
    Grzincic, T.
    Abicic, A.
    Barun, B.
    Gabelic, T.
    Gomezelj, S.
    Pekmezovic, T.
    Klivenyi, P.
    Skoric, M. Krbot
    Habek, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 180 - 180
  • [4] Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
    Moser, Tobias
    Ziemssen, Tjalf
    Sellner, Johann
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2022, 172 (15-16) : 365 - 372
  • [5] Real-World Treatment Patterns and Effectiveness of Cladribine Tablets in Patients with Relapsing Forms of Multiple Sclerosis in the United States
    Song, Y.
    Wang, Y.
    Wong, S. L.
    Yang, D.
    Sundar, M.
    Tundia, N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 203 - 203
  • [6] Real-world treatment patterns and effectiveness of cladribine tablets in patients with relapsing forms of multiple sclerosis in the United States
    Song, Yan
    Wang, Yan
    Wong, Schiffon L.
    Yang, Danni
    Sundar, Manasvi
    Tundia, Namita
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [7] Real-world use of cladribine tablets (Completion rates and treatment persistence) In patients with multiple sclerosis in England: the CLARENCE Study
    Brownlee, W.
    Amin, A.
    Ashton, L.
    Herbert, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 666 - 667
  • [8] Real-world use of cladribine tablets (completion rates and treatment persistence) in patients with multiple sclerosis in England: The CLARENCE study
    Brownlee, Wallace
    Amin, Amerah
    Ashton, Luke
    Herbert, Alex
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [9] A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis
    Aerts, S.
    Khan, H.
    Severijns, D.
    Popescu, V.
    Peeters, L. M.
    Van Wijmeersch, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 892 - 892
  • [10] Cladribine use in multiple sclerosis: a monocentric real-world experience
    Pilotto, Silvy
    Mellino, Paolo
    Carmagnini, Daniele
    Frau, Jessica
    Coghe, Giancarlo
    Cocco, Eleonora
    Lorefice, Lorena
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 639 - 640
12345